1. Home
  2. BNKK vs ADVB Comparison

BNKK vs ADVB Comparison

Compare BNKK & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BNKK

Bonk Inc.

N/A

Current Price

$1.53

Market Cap

10.9M

ML Signal

N/A

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$5.17

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNKK
ADVB
Founded
2018
2014
Country
United States
United States
Employees
10
31
Industry
Package Goods/Cosmetics
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
10.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNKK
ADVB
Price
$1.53
$5.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
290.1K
33.6K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.26
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.19
52 Week High
$7.19
$7.70

Technical Indicators

Market Signals
Indicator
BNKK
ADVB
Relative Strength Index (RSI) 40.34 57.03
Support Level $1.25 $3.71
Resistance Level $2.10 $5.71
Average True Range (ATR) 0.16 0.44
MACD 0.03 0.15
Stochastic Oscillator 35.61 93.06

Price Performance

Historical Comparison
BNKK
ADVB

About BNKK Bonk Inc.

Bonk Inc provides over-the-counter products and consumer products in the United States. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It sells its products through direct customers, distributors, retailers, and e-commerce websites. The company generates revenue through various channels, its primary sales include nostingz suncare products which are sold through e-commerce platforms, licensing revenues from Photocil and sales of the Safety Shot Beverage. The company has two reportable segments: the dietary and energy beverage business and digital assets, consisting of investing for growth in the appreciation of the asset. It derives the majority of the revenue from the dietary and energy beverage segment.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: